Fertility Market Size To Hit US$ 45.40 Billion By 2027

The global fertility market size is expected to hit around USD 45.40 billion by 2027 and progressing a CAGR of 4.7% over the forecast period 2021 to 2027..

Fertality Market Size 2020 to 2027

The on fertility Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1202

Report Scope of the Fertility Market

Report Highlights	Details
Market Size	USD 45.40 Billion by 2027
Growth Rate	CAGR of 4.7% From 2021 to 2027
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2027
Segments Covered	Offering, End user
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

A recent report provides crucial insights along with application based and forecast information in the Global Fertility Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Fertility market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Fertility market are included as given below:

Fertility Market Key Players

Boston IVF Fertility Clinic
INVO Bioscience
San Diego Fertility Center
Celmatix
FUJIFILM IRVINE SCIENTIFIC
Carolinas Fertility Institute
Progyny Inc.
Cook Medical
LifeGlobal Group (Cooper Surgical)

Market Segments

By Offering

Assisted Reproductive Technology
- - IVF
  - Artificial Insemination
  - Surrogacy
  - Others
Fertility Drugs
- - Gonadotropin
  - Anti-estrogen
  - Others
Others

By End user

Fertility Clinics
Hospitals
Clinical Research Institutes

By Geography

North America
- - U.S.
  - Canada
Europe
- - Germany
  - France
  - United Kingdom
  - Rest of Europe
Asia Pacific
- - China
  - Japan
  - India
  - Southeast Asia
  - Rest of Asia Pacific
Latin America
- - Brazil
  - Rest of Latin America
Middle East & Africa (MEA)
- - GCC
  - North Africa
  - South Africa
  - Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global fertility market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the fertility market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Fertility Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Fertility Market

5.1. Covid-19: fertility Industry Impact
5.2. fertility Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and fertility Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for fertility Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Fertility Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Declining fertility rates across the globe
6.1.1.2. Rising number of fertility clinics worldwide, coupled with technological advancements
6.1.2. Market Restraints
6.1.2.1. High procedural cost of assisted reproductive techniques in developed markets
6.1.3. Market Opportunities
6.1.3.1. Use of fertility treatment options by single parents and same-sex couples

Chapter 7. Global Fertility Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. fertility Market Revenue by Market Players (2017 - 2020)
7.1.1.2. fertility Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Fertility Market, By Offering

8.1. fertility Market, by Offering, 2017-2030
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.1.2. IVF
8.1.1.3. Market Revenue and Forecast (2017-2030)
8.1.1.4. Artificial Insemination
8.1.1.5. Market Revenue and Forecast (2017-2030)
8.1.1.6. Surrogacy
8.1.1.7. Market Revenue and Forecast (2017-2030)
8.1.1.8. Others
8.1.1.9. Market Revenue and Forecast (2017-2030)
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.2.2. Gonadotropin
8.1.2.3. Market Revenue and Forecast (2017-2030)
8.1.2.4. Anti-estrogen
8.1.2.5. Market Revenue and Forecast (2017-2030)
8.1.2.6. Others
8.1.2.7. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Fertility Market, By End user

9.1. fertility Market, by Grade, 2017-2030
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Fertility Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Offering (2017-2030)
10.1.2. Market Revenue Forecast by End-user(2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Offering (2017-2030)
10.2.2. Market Revenue Forecast by End-user (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Offering (2017-2030)
10.3.2. Market Revenue Forecast by End-user (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Offering (2017-2030)
10.4.2. Market Revenue Forecast by End-user (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Offering (2017-2030)
10.5.2. Market Revenue Forecast by End-user (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)

Chapter 11. Company Profiles

11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. INVO Bioscience
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. San Diego Fertility Center
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Celmatix
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Carolinas Fertility Institute
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Progyny Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. Cook Medical
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies